Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
University of Virginia
Kyowa Kirin Co., Ltd.
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Syndax Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Syndax Pharmaceuticals
George Washington University
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Taizhou EOC Pharma Co., Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins